16th May 2014 12:03
LONDON (Alliance News) - Venn Life Sciences Holdings PLC Friday posted a widened pretax loss in 2013, as it saw revenue decline, and announced a new contract win. The clinical research organisation posted a pretax loss of EUR1.8 million, widened from EUR1.2 million in the previous year, as Read More